Skip to content
lifestyle.newsblaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Longeveron
Longeveron Announces Engagement of Lucid Capital Markets
October 28, 2026
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
October 26, 2026
Longeveron to Participate in Three Longevity/Aging Investment Conferences
September 30, 2026
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
September 16, 2026
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Longeveron Announces 1-for-10 Reverse Stock Split
August 24, 2026
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
August 19, 2026
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
August 12, 2026
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
August 11, 2026
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
August 3, 2026
1
2
Next Page
→